This HTML5 document contains 42 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n14http://linked.opendata.cz/resource/mesh/concept/
n17http://linked.opendata.cz/resource/drugbank/drug/DB03817/identifier/chebi/
n15http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n11http://linked.opendata.cz/resource/drugbank/drug/DB03817/identifier/kegg-compound/
n8http://linked.opendata.cz/resource/drugbank/drug/DB03817/identifier/pdb/
n9http://linked.opendata.cz/resource/drugbank/drug/DB03817/identifier/pubchem-compound/
n6http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n12http://linked.opendata.cz/resource/drugbank/drug/DB03817/identifier/pubchem-substance/
n13http://linked.opendata.cz/ontology/mesh/
n3http://linked.opendata.cz/ontology/drugbank/
n10http://linked.opendata.cz/resource/drugbank/drug/DB03817/identifier/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB03817
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n6:DB03817 n15:DB03817
dcterms:title
2,4-Diaminobutyric Acid
adms:identifier
n8:DAB n9:134490 n10:DB03817 n11:C03283 n12:46508539 n17:16028
n3:synonym
L-2,4-Diaminobutyrate alpha,gamma-Diaminobutyrate L-2,4-Diaminobutanoate
n13:hasConcept
n14:M0047863
n3:IUPAC-Name
n4:271B4528-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B452E-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B452D-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B452A-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B452B-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B452C-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B4526-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B4527-363D-11E5-9242-09173F13E4C5 n4:271B4524-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B4525-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B4534-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B4535-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B452F-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B4530-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B4532-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B4531-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B4533-363D-11E5-9242-09173F13E4C5
n3:casRegistryNumber
1758-80-1
n3:Bioavailability
n4:271B453A-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B453C-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B453D-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B4539-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B4538-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B453B-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B4529-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B4536-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B4537-363D-11E5-9242-09173F13E4C5